122 related articles for article (PubMed ID: 28378637)
1. Primary Tr1 cells from metastatic melanoma eliminate tumor-promoting macrophages through granzyme B- and perforin-dependent mechanisms.
Yan H; Zhang P; Kong X; Hou X; Zhao L; Li T; Yuan X; Fu H
Tumour Biol; 2017 Apr; 39(4):1010428317697554. PubMed ID: 28378637
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
Czystowska M; Strauss L; Bergmann C; Szajnik M; Rabinowich H; Whiteside TL
J Mol Med (Berl); 2010 Jun; 88(6):577-88. PubMed ID: 20225066
[TBL] [Abstract][Full Text] [Related]
3. Granzyme B-expressing treg cells are enriched in colorectal cancer and present the potential to eliminate autologous T conventional cells.
Sun B; Liu M; Cui M; Li T
Immunol Lett; 2020 Jan; 217():7-14. PubMed ID: 31669380
[TBL] [Abstract][Full Text] [Related]
4. The decreased susceptibility of metastatic melanoma cells to killing involves an alteration of CTL reactivity.
Gassara A; Messai Y; Gaudin C; Abouzahr S; Jalil A; Diarra-Mehrpour M; Faure F; Richon C; Avril MF; Even J; Chouaib S
Int J Oncol; 2006 Jul; 29(1):155-61. PubMed ID: 16773195
[TBL] [Abstract][Full Text] [Related]
5. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.
Cao X; Cai SF; Fehniger TA; Song J; Collins LI; Piwnica-Worms DR; Ley TJ
Immunity; 2007 Oct; 27(4):635-46. PubMed ID: 17919943
[TBL] [Abstract][Full Text] [Related]
6. Granulysin- and granzyme-dependent elimination of myeloid cells by therapeutic ova-specific type 1 regulatory T cells.
Guipouy D; Gertner-Dardenne J; Pfajfer L; German Y; Belmonte N; Dupré L
Int Immunol; 2019 Mar; 31(4):239-250. PubMed ID: 30778577
[TBL] [Abstract][Full Text] [Related]
7. Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.
Magnani CF; Alberigo G; Bacchetta R; Serafini G; Andreani M; Roncarolo MG; Gregori S
Eur J Immunol; 2011 Jun; 41(6):1652-62. PubMed ID: 21469116
[TBL] [Abstract][Full Text] [Related]
8. Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody.
Choi BD; Gedeon PC; Herndon JE; Archer GE; Reap EA; Sanchez-Perez L; Mitchell DA; Bigner DD; Sampson JH
Cancer Immunol Res; 2013 Sep; 1(3):163. PubMed ID: 24570975
[TBL] [Abstract][Full Text] [Related]
9. Neem leaf glycoprotein suppresses regulatory T cell mediated suppression of monocyte/macrophage functions.
Chakraborty T; Bose A; Goswami KK; Goswami S; Chakraborty K; Baral R
Int Immunopharmacol; 2012 Feb; 12(2):326-33. PubMed ID: 22210373
[TBL] [Abstract][Full Text] [Related]
10. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
11. Rat CD4+CD8+ macrophages kill tumor cells through an NKG2D- and granzyme/perforin-dependent mechanism.
Baba T; Iwasaki S; Maruoka T; Suzuki A; Tomaru U; Ikeda H; Yoshiki T; Kasahara M; Ishizu A
J Immunol; 2008 Mar; 180(5):2999-3006. PubMed ID: 18292522
[TBL] [Abstract][Full Text] [Related]
12. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
[TBL] [Abstract][Full Text] [Related]
13. Overrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4+ T Cell Activity in HBV-Induced Hepatocellular Carcinoma.
Xue H; Lin F; Tan H; Zhu ZQ; Zhang ZY; Zhao L
PLoS One; 2016; 11(5):e0154815. PubMed ID: 27136203
[TBL] [Abstract][Full Text] [Related]
14. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
15. CD4
Li Z; Liu X; Guo R; Wang P
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):1-9. PubMed ID: 27644153
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.
Cifaldi L; Prencipe G; Caiello I; Bracaglia C; Locatelli F; De Benedetti F; Strippoli R
Arthritis Rheumatol; 2015 Nov; 67(11):3037-46. PubMed ID: 26251193
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of granzyme B and perforin by staphylococcal enterotoxin C2 mutant induces enhanced cytotoxicity in Hepa1-6 cells.
Zhang G; Xu M; Zhang H; Song Y; Wang J; Zhang C
Toxicol Appl Pharmacol; 2016 Dec; 313():1-9. PubMed ID: 27742270
[TBL] [Abstract][Full Text] [Related]
18. CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2013 Feb; 74(2):151-62. PubMed ID: 23017670
[TBL] [Abstract][Full Text] [Related]
19. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CD8
Li GG; Cao YH; Run Y; Xu RX; Zheng ZD
Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1191-1198. PubMed ID: 27558304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
